Literature DB >> 22797563

Dynamic patient counseling: a novel concept in idiopathic pulmonary fibrosis.

A Whitney Brown1, Oksana A Shlobin1, Nargues Weir1, Maria C Albano2, Shahzad Ahmad1, Mary Smith1, Kevin Leslie3, Steven D Nathan4.   

Abstract

BACKGROUND: The characteristics of long-term survivors with idiopathic pulmonary fibrosis (IPF) have never been fully elucidated. We sought to illustrate the attenuated mortality and describe the characteristics of patients with IPF who survived at least 5 years beyond their initial presentation.
METHODS: Patients with IPF evaluated between 1997 and 2006 were identified through the clinic database. Patients who survived beyond 5 years from the time of their evaluation were compared with those who died or underwent lung transplantation within 5 years. Survival analyses were performed from the time of initial evaluation and contingent on annualized survival thereafter.
RESULTS: Eighty-seven patients who survived at least 5 years formed the comparator group to whom other patients were contrasted. These patients had a higher BMI, FVC % predicted, FEV1 % predicted, total lung capacity % predicted, and diffusing capacity of lung for carbon monoxide % predicted, but a lower FEV1/FVC ratio and lower mean pulmonary artery pressures. More than one-half of these patients had moderate or severe disease at the time of presentation. Our annualized contingent survival analyses revealed a progressively increasing median survival dependent on the duration of the disease.
CONCLUSIONS: Although we were able to demonstrate differences in our 5-year survivors, rather than being a distinct group, these patients appear to exist within a continuum of improving survival dependent on prior disease duration. This progressively improving time-dependent prognosis mandates the serial reevaluation of an individual patient’s projected outcomes. The implementation of dynamic counseling is an important concept in more accurately predicting life expectancy for patients with IPF who are frequently haunted by the prospects of a dismal survival.

Entities:  

Mesh:

Year:  2012        PMID: 22797563     DOI: 10.1378/chest.12-0298

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  10 in total

1.  Pulmonary function and survival in idiopathic vs secondary usual interstitial pneumonia.

Authors:  Matthew J Strand; David Sprunger; Gregory P Cosgrove; Evans R Fernandez-Perez; Stephen K Frankel; Tristan J Huie; Amy L Olson; Joshua Solomon; Kevin K Brown; Jeffrey J Swigris
Journal:  Chest       Date:  2014-09       Impact factor: 9.410

Review 2.  Indications for lung transplant referral and listing.

Authors:  Omar Shweish; Goutham Dronavalli
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

Review 3.  Lung transplantation: indications and contraindications.

Authors:  David Weill
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  The natural history of idiopathic pulmonary fibrosis in a large European population: the role of age, sex and comorbidities.

Authors:  Antonella Caminati; Fabiana Madotto; Sara Conti; Giancarlo Cesana; Lorenzo Mantovani; Sergio Harari
Journal:  Intern Emerg Med       Date:  2021-02-14       Impact factor: 3.397

Review 5.  Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research.

Authors:  Eugenia Vlaskou Badra; Michael Baumgartl; Silvia Fabiano; Aurélien Jongen; Matthias Guckenberger
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 6.  Korean Guidelines for Diagnosis and Management of Interstitial Lung Diseases: Part 2. Idiopathic Pulmonary Fibrosis.

Authors:  Sang Hoon Lee; Yoomi Yeo; Tae Hyung Kim; Hong Lyeol Lee; Jin Hwa Lee; Yong Bum Park; Jong Sun Park; Yee Hyung Kim; Jin Woo Song; Byung Woo Jhun; Hyun Jung Kim; Jinkyeong Park; Soo Taek Uh; Young Whan Kim; Dong Soon Kim; Moo Suk Park
Journal:  Tuberc Respir Dis (Seoul)       Date:  2019-02-28

Review 7.  Idiopathic Pulmonary Fibrosis: Epidemiology, Natural History, Phenotypes.

Authors:  Jaume Sauleda; Belén Núñez; Ernest Sala; Joan B Soriano
Journal:  Med Sci (Basel)       Date:  2018-11-29

Review 8.  Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible.

Authors:  Elisabetta Balestro; Elisabetta Cocconcelli; Mariaenrica Tinè; Davide Biondini; Eleonora Faccioli; Marina Saetta; Federico Rea
Journal:  Medicina (Kaunas)       Date:  2019-10-19       Impact factor: 2.430

9.  Body mass index and in-hospital mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis.

Authors:  Nobuyasu Awano; Taisuke Jo; Hideo Yasunaga; Minoru Inomata; Naoyuki Kuse; Mari Tone; Kojiro Morita; Hiroki Matsui; Kiyohide Fushimi; Takahide Nagase; Takehiro Izumo
Journal:  ERJ Open Res       Date:  2021-06-28

10.  Retrospective cohort study of patients qualified for lung transplantation due to idiopathic pulmonary fibrosis - single-centre experience.

Authors:  Marek Ochman; Maciej Urlik; Zofia Tatoj; Fryderyk Zawadzki; Marta Wajda-Pokrontka; Magdalena Latos; Piotr Przybyłowski; Marian Zembala
Journal:  Arch Med Sci       Date:  2019-01-30       Impact factor: 3.318

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.